Boston Scientific Poised for Another Earnings Surprise

Boston Scientific (BSX) shows strong potential for beating earnings estimates in its next report. With an average surprise of 7.76% over the last two quarters, the company’s consistent performance may positively impact stock prices.

Date: 01-01-2025

AI Rating: 7

Earnings Per Share (EPS)
Boston Scientific reported earnings of $0.63 per share, exceeding the Zacks Consensus Estimate of $0.58 by 8.62%. This follows the previous quarter where the company also surpassed expectations with an EPS of $0.62 against an estimate of $0.58, reflecting a surprise of 6.90%. Such consistent performance in beating EPS estimates is a positive indicator for investor sentiment regarding its stock price.

Positive Earnings ESP
The company currently has an Earnings ESP of +1.24%, indicating that analysts have revised their earnings estimates upwards, which is a bullish sign for potential future earnings beats. Coupled with a Zacks Rank of #2 (Buy), this suggests that the likelihood of a positive earnings surprise in the upcoming report is high, which can result in upward pressure on stock prices.

Analyst Sentiment
The upward revision of earnings estimates and strong historical performance can create a favorable atmosphere for Boston Scientific. Generally, stocks with a positive Earnings ESP tend to outperform expectations, potentially bolstering investor interest and driving stock prices higher. The analysis indicates that stocks with this combination have a success rate of beating the consensus estimate nearly 70% of the time.

Stocks: BSX